Hill-Rom Holdings Market Cap 2006-2020 | HRC

Hill-Rom Holdings market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Hill-Rom Holdings market cap as of December 03, 2020 is $6.42B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.425B $2.881B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.284B 34.44
Medtronic (MDT) Ireland $150.740B 30.64
Stryker (SYK) United States $86.808B 32.49
Boston Scientific (BSX) United States $48.184B 28.28
Lonza Group Ag (LZAGY) Switzerland $45.932B 0.00
Baxter (BAX) United States $38.572B 23.16
EssilorLuxottica Societe Anonyme (ESLOY) France $33.144B 0.00
ResMed (RMD) United States $30.665B 41.49
Zimmer Biomet Holdings (ZBH) United States $30.283B 24.93
Terumo (TRUMY) Japan $30.252B 38.67
Sunny Optical Technology (SNPTF) China $21.586B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.729B 0.00
Insulet (PODD) United States $17.311B 596.75
Bio-Rad Laboratories (BIO) United States $16.624B 63.04
DiaSorin S.p.A (DSRLF) Italy $11.581B 0.00
GN STORE NORD (GNNDY) Denmark $10.027B 51.11
Canopy Growth (CGC) Canada $9.920B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $9.045B 0.00
William Demant Holdings (WILYY) Denmark $8.605B 0.00
Quidel (QDEL) United States $7.949B 19.81
Perrigo (PRGO) Ireland $6.613B 11.65
Haemonetics (HAE) United States $5.715B 41.53
Envista Holdings (NVST) United States $4.800B 32.33
GW Pharmaceuticals (GWPH) United Kingdom $4.261B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.072B 0.00
ICU Medical (ICUI) United States $3.965B 29.76
Neogen (NEOG) United States $3.964B 64.99
TG Therapeutics (TGTX) United States $3.696B 0.00
National Vision Holdings (EYE) United States $3.462B 90.92
Agios Pharmaceuticals (AGIO) United States $3.223B 0.00
DFB Healthcare Acquisitions (AHCO) United States $3.179B 161.23
NanoString Technologies (NSTG) United States $2.407B 0.00
NuVasive (NUVA) United States $2.384B 34.43
Aphria (APHA) Canada $2.284B 0.00
AtriCure (ATRC) United States $1.946B 0.00
Owens & Minor (OMI) United States $1.900B 20.03
InMode (INMD) Israel $1.433B 32.24
Cardiovascular Systems (CSII) United States $1.392B 0.00
Quanterix (QTRX) United States $1.390B 0.00
Aurora Cannabis (ACB) Canada $1.378B 0.00
MacroGenics (MGNX) United States $1.331B 0.00
BioLife Solutions (BLFS) United States $1.145B 1166.33
Cerus (CERS) United States $1.135B 0.00
Lantheus Holdings (LNTH) United States $0.900B 16.02
OraSure Technologies (OSUR) United States $0.884B 0.00
PetIQ (PETQ) United States $0.834B 47.64
BellRing Brands (BRBR) United States $0.822B 34.75
Meridian Bioscience (VIVO) United States $0.818B 17.75
Omeros (OMER) United States $0.776B 0.00
LeMaitre Vascular (LMAT) United States $0.763B 40.31
Phibro Animal Health (PAHC) United States $0.741B 15.79
Varex Imaging (VREX) United States $0.647B 183.33
Vapotherm (VAPO) United States $0.644B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.609B 43.24
HEXO (HEXO) $0.517B 0.00
Surmodics (SRDX) United States $0.516B 315.83
Zynex (ZYXI) United States $0.467B 43.35
Viemed Healthcare (VMD) United States $0.375B 13.32
Cytosorbents (CTSO) United States $0.357B 0.00
Surface Oncology (SURF) United States $0.334B 0.00
InfuSystems Holdings (INFU) United States $0.332B 46.83
Utah Medical Products (UTMD) United States $0.319B 29.09
Organigram Holdings (OGI) Canada $0.297B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Bovie Medical (APYX) United States $0.254B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.225B 0.00
Chimerix (CMRX) United States $0.222B 0.00
Wound Management Technologies (SMTI) United States $0.217B 0.00
Female Health (VERU) United States $0.212B 0.00
Exagen (XGN) United States $0.180B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Chembio Diagnostics (CEMI) United States $0.131B 0.00
Evolus (EOLS) United States $0.124B 0.00
Fonar (FONR) United States $0.122B 17.89
Green Organic Dutchman Holdings (TGODF) Canada $0.111B 0.00
Rockwell Medical (RMTI) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Capricor Therapeutics (CAPR) United States $0.085B 0.00
MTech Acquisition (KERN) United States $0.073B 0.00
Brainsway (BWAY) Israel $0.070B 0.00
United-Guardian (UG) United States $0.066B 15.94
Nephros (NEPH) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Myomo (MYO) United States $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.023B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 8.17